This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal

JUHN WADA, M.D.; WILLIAM C. GIBSON, M.D.

A.M.A. Arch Neurol Psychiatry. 1959;81(6):747-764.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Introduction

The present growth of interest in biological studies in psychiatry has been accelerated by a rapidly increasing body of knowledge concerning (1) the psychotherapeutic action of reserpine and chlorpromazine, and (2) psychotomimetic action of so-called hallucinogenic agents, such as lysergic acid and mescaline.

The recognition of a common denominator among these agents—an activated aromatic ring²⁹—and the presence of a number of independent reports in the literature concerning the abnormally high concentration of various aromatic derivatives in the schizophrenic body fluids^24,25 led McGeer et al. to suspect the possible significance of aromatic metabolism in schizophrenia.

On the basis of the one-dimensional chromatographic analysis of several hundred schizophrenic and nonschizophrenic subjects, they found that the patients with acute schizophrenia generally excreted more aromatic compounds than did the nonschizophrenics. Further analysis with extracts of urine pools from groups of schizophrenic as against nonschizophrenic subjects indicated that there are several . . . [Full Text PDF of this Article]

Author Affiliations
Vancouver, B. C., Canada

From the Department of Neurological Research, University of British Columbia Faculty of Medicine.

Footnotes
Submitted for publication June 21, 1958.

Aided by Federal Mental Health Grant #609-5-123 and by the Provincial Mental Health Services of British Columbia.